Leukemia Research
Volume 28, Issue 3 , Pages 229-236 , March 2004

T-cell-rich B-cell lymphoma: a clinicopathologic study of 21 cases and comparison with 43 cases of diffuse large B-cell lymphoma

  • Hilal Aki

      Affiliations

    • Division of Hematopathology, Department of Pathology, Cerrahpasa Tıp Fakultesi, Istanbul Universitesi, Patoloji Anabilim Dali, Istanbul 34303, Turkey
    • ,
  • Nukhet Tuzuner

      Affiliations

    • Division of Hematopathology, Department of Pathology, Cerrahpasa Tıp Fakultesi, Istanbul Universitesi, Patoloji Anabilim Dali, Istanbul 34303, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90-216-521-15-88; fax: +90-212-587-77-00.
    • ,
  • Seniz Ongoren

      Affiliations

    • Division of Hematology, Department of Internal Medicine, Cerrahpasa Tıp Fakultesi, Istanbul Universitesi, Patoloji Anabilim Dali, Istanbul 34303, Turkey
    • ,
  • Zafer Baslar

      Affiliations

    • Division of Hematology, Department of Internal Medicine, Cerrahpasa Tıp Fakultesi, Istanbul Universitesi, Patoloji Anabilim Dali, Istanbul 34303, Turkey
    • ,
  • Teoman Soysal

      Affiliations

    • Division of Hematology, Department of Internal Medicine, Cerrahpasa Tıp Fakultesi, Istanbul Universitesi, Patoloji Anabilim Dali, Istanbul 34303, Turkey
    • ,
  • Burhan Ferhanoglu

      Affiliations

    • Division of Hematology, Department of Internal Medicine, Cerrahpasa Tıp Fakultesi, Istanbul Universitesi, Patoloji Anabilim Dali, Istanbul 34303, Turkey
    • ,
  • Ismet Sahinler

      Affiliations

    • Department of Radiotherapy, Cerrahpasa Tıp Fakultesi, Istanbul Universitesi, Patoloji Anabilim Dali, Istanbul 34303, Turkey
    • ,
  • Yıldız Aydın

      Affiliations

    • Division of Hematology, Department of Internal Medicine, Cerrahpasa Tıp Fakultesi, Istanbul Universitesi, Patoloji Anabilim Dali, Istanbul 34303, Turkey
    • ,
  • Birsen Ulku

      Affiliations

    • Division of Hematology, Department of Internal Medicine, Cerrahpasa Tıp Fakultesi, Istanbul Universitesi, Patoloji Anabilim Dali, Istanbul 34303, Turkey
    • ,
  • Gulten Aktuglu

      Affiliations

    • Division of Hematology, Department of Internal Medicine, Cerrahpasa Tıp Fakultesi, Istanbul Universitesi, Patoloji Anabilim Dali, Istanbul 34303, Turkey

Received 4 March 2003 ,Accepted 25 June 2003.

References 

  1. Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am. J. Surg. Pathol. 1988;12:433–443
  2. Jaffe ES. Pseudoperipheral T cell lymphomas. In: Jaffe ES, editor. Surgical pathology of lymph nodes and related organs. Philadelphia, PA: Saunders; 1985. p. 230–1.
  3. Harris NL, Jaffe ES, Stein H, et al.  A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–1392
  4. Gatter KC, Warnke RA. Diffuse large B cell lymphoma. In: Jaffe ES, Harris NL, Variman JW, editors. Pathology and genetics of tumors of hematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 171–4.
  5. Macon WR, Williams ME, Greer JP, Stein RS, Collins RD, Cousar JB. T-cell-rich B-cell lymphomas. A clinicopathological study of 19 cases. Am. J. Surg. Pathol. 1992;16:351–368
  6. Mc Bride JA, Rodriguez J, Luthra R, Ordonez NG, Cabanillas F, Pugh WC. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin’s disease. Am. J. Surg. Pathol. 1996;20:193–201
  7. Krishnan J, Wallberg K, Frizzera G. T-cell-rich large B-cell lymphoma: a study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness. Am. J. Surg. Pathol. 1994;18:455–465
  8. Schmidt U, Metz KA, Leder LD. T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin’s disease: two closely related entities?. Br. J. Haematol. 1995;90:398–403
  9. Anagnostopoulos I, Hansmann ML, Franssila K, et al.  European Task Force on Lymphoma project on lymphocyte predominance Hodgkin’s disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with nodular growth pattern and abundant lymphocytes. Blood. 2000;96:1889–1899
  10. Rüdiger T, Gascoyne RD, Jaffe ES, et al.  Workshop on the relationship between nodular lymphocyte predominant Hodgkin’s lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann. Oncol. 2002;13(suppl):44–51
  11. Ng CS, Chan JKC, Hui PK, Lau WH. Large B-cell lymphomas with a high content of reactive T-cells. Hum. Pathol. 1989;20:1145–1154
  12. Rodriguez J, Pugh C, Cabanillas F. T-cell-rich B-cell lymphoma. Blood. 1993;82:1586–1589
  13. Greer JP, Macon WR, Lamar RE, Wolff SN, Stein RS, Flexner JM, et al.  T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients. J. Clin. Oncol. 1995;13:1742–1750
  14. Skinnider BF, Connors JM, Gascoyne RD. Bone marrow involvement in T-cell-rich B-cell lymphoma. Am. J. Clin. Pathol. 1997;108:570–578
  15. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 1993;329:987–94.
  16. Carbone PP, Kaplan HS, Musshoff K, Simithers DW, Tubiana M. Report of the committee on Hodgkin’s disease staging classification. Cancer Res. 1991;31:1860–1861
  17. Cheson BD, Horning SJ, Coiffier B, et al.  Report of an International Workshop to standardise response criteria for non-Hodgkin’s lymphomas. J. Clin. Oncol. 1999;17:1244–1253
  18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958;53:457–481
  19. Peto R, Pike MC, Armitage P, et al.  Design analysis of randomised clinical trials requiring prolonged observations of each patient. II. Analysis and examples. Br. J. Cancer. 1977;35:1–39
  20. Coiffier B. Diffuse large cell lymphoma. Curr. Opin. Oncol. 2001;13:325–334
  21. Maes B, Anastasopoulou A, Kluin-Nelemans JC, et al.  Among diffuse large B cell lymphomas, T-cell-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features. Ann. Oncol. 2001;12:853–858
  22. Engelhard M, Brittinger G, Huhn D, et al.  Subclassification of diffuse large B cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant risk factor. Blood. 1997;89:2291–2297
  23. Boddoura FK, Chan WC, Maish AS, Mitchell D, Sun NCJ, Weisenburger DD. T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases. Am. J. Clin. Pathol. 1995;103:65–75
  24. Jaffe ES, Longo DL, Cossman J. Diffuse B-cell lymphomas with T-cell predominance in patients with follicular lymphoma or “pseudo T cell lymphoma”. Lab. Invest. 1984;50:27A–28A (abstract)
  25. Osborne BM, Butler JJ, Pugh WC. The value of immunophenotyping on paraffin sections in the identification of T-cell-rich B-cell large cell lymphomas: lineage confirmed by JH rearrangement. Am. J. Surg. Pathol. 1990;14:933–938
  26. de Wolf-Peeters C, Pittaluga S. T-cell rich B-cell lymphoma: a morphological variant of a variety of non-Hodgkin’s lymphomas or a clinicopathological entity? (comment). Histopathology. 1995;26(3):83–85
  27. De Jong D, van Gorp J, Sie-Go D, van Heerde P. T-cell rich B-cell non-Hodgkin’s lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin’s disease. Histopathology. 1996;28:15–24
  28. Rüdiger T, Ott G, Ott MM, Müller-Deubert SM, Müller-Hermelink HK. Differential diagnosis between Hodgkin’s lymphoma, T-cell rich-cell lymphoma and paragranuloma by paraffin immunohistochemistry. Am. J. Surg. Pathol. 1998;22:1184–1191
  29. Kamel OW, Gelb AB, Shibuya RB, Warnke RA. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominant Hodgkin’s disease from nodular sclerosing Hodgkin’s disease, T-cell rich B-cell lymphoma and follicular lymphoma. Am. J. Pathol. 1993;142:541–546
  30. Chittal SM, Brousset P, Voigt JJ, Delsol G. Large B-cell lymphoma rich in T cells and simulating Hodgkin’s disease. Histopathology. 1991;19:211–220
  31. Diehl V, Sextro M, Franklin J, et al.  Clinical presentation, course and prognostic factors in lymphocyte predominant Hodgkin’s disease and lymphocyte rich classical Hodgkin’s disease: report from the European Task Force on Lymphoma Project on lymphocyte predominant Hodgkin’s disease. J. Clin. Oncol. 1999;17:776–783
  32. Yan Y, Chan WC, Weisenburger DD, Anderson JR, Bast MA, Vose JM. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. J. Clin. Oncol. 1995;13:1336–1342
  33. Brauninger A, Küppers R, Spieker T, et al.  Molecular analysis of single B cells from T cell rich B cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. Blood. 1999;93:2679–2687
  34. Bouabdallah R, Mounier N, Guettier T, et al.  T-cell/histiocyte-rich large B cell lymphomas and classical diffuse large B cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. J. Clin. Oncol. 2003;21:1271–1277
  35. Gascoyne R, Delabie J, Connors JM, et al. Paragranuloma-type T/HRLBL: a report of 53 cases. In: Rudiger T, Gascoyne RD, Jaffe ES, et al., editors. Symposium article, workshop on the relation between nodular lymphocyte predominant Hodgkin’s lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol 2002;13(suppl):44–51.

PII: S0145-2126(03)00253-4

doi: 10.1016/S0145-2126(03)00253-4

Leukemia Research
Volume 28, Issue 3 , Pages 229-236 , March 2004

Article Tools

* Image Usage & Resolution